Collegium Pharmaceutical, Inc. (COLL)

48.71 -0.30 (-0.61%) USD  |  NASDAQ  |  Dec 16, 16:00
48.95 +0.24 (+0.49%) Pre-Market: 08:15
More

Collegium Pharmaceutical Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Altimmune, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade